Literature DB >> 15635083

The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients.

K Eliason, B C Hendrickson, T Judkins, M Norton, B Leclair, E Lyon, B Ward, W Noll, T Scholl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15635083      PMCID： PMC1735918          DOI： 10.1136/jmg.2004.025973

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  13 in total

1.  Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP).

Authors:  Muhammad Ali Pervaiz; Amanda Eppolito; Karen Schmidt
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.

Authors:  Carlos E Pitroski; Silvia Liliana Cossio; Patrícia Koehler-Santos; Marcia Graudenz; João Carlos Prolla; Patricia Ashton-Prolla
Journal:  Int J Colorectal Dis       Date:  2011-03-22       Impact factor: 2.571

3.  MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer.

Authors:  Astrid Stormorken; Karen-Marie Heintz; Per Arne Andresen; Eivind Hovig; Pål Møller
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

4.  Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.

Authors:  Erin G Sutcliffe; Amanda Bartenbaker Thompson; Amy R Stettner; Megan L Marshall; Maegan E Roberts; Lisa R Susswein; Ying Wang; Rachel T Klein; Kathleen S Hruska; Benjamin D Solomon
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

5.  Characterization of mutant MUTYH proteins associated with familial colorectal cancer.

Authors:  Mohsin Ali; Hyeja Kim; Sean Cleary; Claire Cupples; Steven Gallinger; Robert Bristow
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

6.  Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.

Authors:  Allison W Kurian; Emily E Hare; Meredith A Mills; Kerry E Kingham; Lisa McPherson; Alice S Whittemore; Valerie McGuire; Uri Ladabaum; Yuya Kobayashi; Stephen E Lincoln; Michele Cargill; James M Ford
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

7.  MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.

Authors:  Stefan Aretz; Rossella Tricarico; Laura Papi; Isabel Spier; Elisa Pin; Sukanya Horpaopan; Emanuela Lucci Cordisco; Monica Pedroni; Dietlinde Stienen; Annamaria Gentile; Anna Panza; Ada Piepoli; Maurizio Ponz de Leon; Waltraut Friedl; Alessandra Viel; Maurizio Genuardi
Journal:  Eur J Hum Genet       Date:  2013-01-30       Impact factor: 4.246

Review 8.  Genetic testing for hereditary colorectal cancer.

Authors:  Heather Hampel
Journal:  Surg Oncol Clin N Am       Date:  2009-10       Impact factor: 3.495

9.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

10.  Base excision repair and the role of MUTYH.

Authors:  Carla Kairupan; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.